Abstract
Osteosclerosis is characterized by an increase in skeletal mass (hyperostosis), usually involving both cortical and cancellous bone. In spite of the increase in density the affected bones are more fragile. Osteosclerosis is caused by increased bone formation, reduced bone resorption or both, and may be either inherited or acquired13,40. The osteoscleroses may be local, multifocal or generalized, and result from a variety of metabolic, inflammatory, toxic or neoplastic disorders in addition to the congenital forms1,3,9. The commoner syndromes which present with increased bone density are listed in Table 10.1. Those not related to metabolic and hereditary disorders will be discussed in the appropriate chapters. Increments in bone mass are manifest radiologically as increased osseous density, with variable alterations of the architecture of the bones involved6,27.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beighton P., Horan F. and Hammersma H. (1977). A review of the osteoscleroses. Postgrad. Med. J., 53 507
Bollerslev J., Nielsen H. K., Storm T. and Mosekilde L. (1988). Serum vitamin D metabolites and nuclear uptake of (3H)-1,25- dihydroxyvitamin D 3 in monocytes from patients with autosomal dominant osteopetrosis: a study of two radiological types. Calcif. Tissue Int., 43(2), 67
Bowley N. B. (1984). Osteosclerosis. Nordin B. E. C., Metabolic Bone and Stone Disease (p. 234). Edinburgh: Churchill Livingstone
Burr D. B. and Martin R. B. (1988). Errors in bone remodeling: toward a unified theory of metabolic bone disease. Amer. J. Anat., 186 186
Coccia P. F., Krivit W., Cervenka J., Clawson C., Kersey J., Kim T. H., Nesbit M. E., Ramsay M. K. C., Warkentin P. I., Teitelbaum S. L., Kahn A. J. and Brown D. M. (1980). Successful bone marrow transplantation for infantile malignant osteopetrosis. N. Engl. J. Med., 302 701
Edeiken J., Dalinka M. and Karasick D. (1990). Edeiken’s Roentgen Diagnosis of Diseases of Bone. Baltimore: Williams & Wilkins
Evans R. A., Hughes W. G., Dunstan C. R., Lennon W. P., Kohan L., Hills E. and Wong S. Y. P. (1983). Adult osteopetrosis. Metab. Bone Dis. Rel. Res., 5 111
Glorieux F. H., Pettifor J. M., Marie P. J., Delvin E. E., Travers R. and Shepard N. (1981). Induction of bone resorption by parathyroid hormone in congenital malignant osteopetrosis. Metab. Bone Dis. Rel. Res., 3 143
Grech P., Martin T. J., Barrinton N. A. and Ell P. J. (1985). Diagnosis of Metabolic Bone Disease. London: Chapman & Hall
Gruber H. E. and Baylink D. J. (1991). The effects of fluoride on bone. Clin. Orthop., 267 264
Hochmann N., Wahl L. M. and Sandberg A. L. (1982). Co-existence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats. J. Immunol., 129 278
Horton W. A., Schimke R. N. and Lyama T. (1980). Osteopetrosis: further heterogeneity. J. Pediatr., 97 580
Johnston C. C., Lavy N., Lord T., Vellios F., Merrit A. D. and Deiss W. P. (1968). Osteopetrosis: a clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine, 47 149
Khoker M. A. and Dandona P. (1990). Fluoride stimulates (3D) thymidine incorporation and alkaline phosphatase production by human osteoblasts. Metabolism, 39(11) 1118
Kumar B., Murphy W. A. and Whyte M. P. (1981). Progressive diaphyseal dysplasia (Engelmann disease): scintigraphic-radiographic-clinical correlations. Radiology, 140 87
Labat M.-L. and Milhaud G. (1986). Osteopetrosis and the immune deficiency syndrome. Peck W. A., Bone and Mineral Research, vol. 4 (p. 131). Amsterdam: Elsevier
Marks C. R., Seifert M. F. and Marks S. C. (1984). Osteoclast populations in congenital osteopetrosis: additional evidence of heterogeneity. Metab. Bone Dis. Rel. Res., 5 259
Marks S. C. (1987). Osteopetrosis - multiple pathways for the interception of osteoclast function. Appl Pathol., 5 172
Marks S. C. (1973). Pathogenesis of osteopetrosis in the is rat: reduced bone resorption due to reduced osteoclast function. Amer. J. Anat., 138 165
Marks S. C. and McGuire J. L. (1989). Primary bone cell dysfunction II-osteopetrosis. Tam C. S., Heersche J. N. M. and Murray T. M., Metabolic Bone Disease: Cellular and Tissue Mechanism (p. 49). Boca Raton: CRC Press)
Marks S. C. and Walker D. G. (1981). The hematogenous origin of osteoclasts: experimental evidence of osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors. Amer. J. Anat., 161 1
Meunier P. J., Femenias M., Duboeuf F., Chapuy M. C. and Delmas P. D. (1989). Increased vertebral bone density in heavy drinkers of mineral water rich in fluoride. Lancet, 45(1), 152
Milgram J. W. and Jasty M. (1982). Osteopetrosis: a morphological study of twenty-ope cases. J. Bone Jt Surg., 64A 912
Milhaud G., Labat M. L., Litwin I., Moricard Y., Moutier R., Rimbaut C., Buffe D. and Juster M. (1981). Osteopetro-rickets: a new congenital bone disorder. Metab. Bone Dis. Rel. Res., 3 91
Milhaud G. and Labat M. L. (1978). Thymus and osteopetrosis. Clin. Orthop., 135 260
Mills B.-G., Yake H. and Singer F. R. (1988). Osteoclasts in human osteopetrosis contain viral nucleocapsid-like nuclear inclusions. J. Bone Miner. Res., 3(1), 101
Murray R. O., Jacobson H. G. and Stoker D. J. (1990). The Radiology of Skeletal Disorders. Edinburgh: Churchill Livingstone
Nisbet N. W., Menage J. and Loutit J. F. (1982). Osteogenesis in osteopetrotic mice. Calcif. Tissue Int., 34 37
Pounds J. G., Long G. J. and Rosen J. F. (1991). Cellular and molecular toxicity of lead in bone. Environ. Health Perspect, 91 17
Reeves J., Arnaud S., Gordon S., Subryan B., Block M., Huffer W., Arnaud C., Mundy G. and Haussler M. (1981). The pathogenesis of infnatile malignant osteopetrosis: bone mineral metabolism, and complications in five infants. Metab. Bone Dis. Rel. Res.,3 135
Revell P. A. (1986). Pathology of Bone. Berlin: Springer
Rouleau M., Warshawsky H., Marks S. C. and Goltzman D. (1986). Calcitonin receptor binding as a marker of osteoclast heterogeneity in osteopetrotic rodents. J. Bone Miner. Res., 1 543
Schneider G. B. (1978). The role of lymphoid cells in bone resorption. Cellular immunologic competence in is rats. Amer. J. Anat, 153 305
Sear H. R. (1948). Engelmann’s disease. Brit. J. Radiol., 21 236
Shapiro F., Glimcher M. J., Holtrop M. E., Tashjian A. H., Brickley-Parsons D. and Kenzora J. E. (1980). Human osteopetrosis. J. Bone Jt Surg., 62A 384
Sly W. S., Whyte M. P. and Sundaram V. (1985). Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N. Engl. J. Med., 313 139
Smith R. E. and Morgan J. H. (1984). Pathogenesis of osteopetrosis induced by rapid and slow onset plaque isolated of an avian osteopetrosis virus. Metab. Bone Dis. Rel. Res., 5 289
Volker G. (1981). Diagnosis of osteopetrosis (Albers-Schonberg) by Jamshidi needle biopsy. Hum. Pathol., 12 198
Walker D. G. (1975). Control of bone resorption by hematopoietic tissue. The induction and reversal of congenital osteopetrosis in mice through use of bone marrow and splenic transplants. J. Exp. Med., 142 651
Whyte M. P. (1990). Heritable metabolic and dysplastic bone disease. Endocrinol. Metab. Clin. N. Amer, 19(1) 133
Wiktor-Jedrzejczak W., Ahmed A., Szczylik C. and Skelly R. R. (1982). Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J. Exp. Med., 156 1516
Zerwekh J. E., Morris A. C., Padalino P. K., Gottschalk F. and Pak C. Y. (1990). Fluoride rapidly and transiently raises intracellular calcium in human osteoblasts. J. Bone Miner. Res., 5(1), 131
Villareal D. T., Murphy W. A., Teitelbaum S. T., Arens M. Q. and Whyte M. P. (1992). Painful diffuse osteosclerosis after intravenous drug abuse. Amer. J. Med., 93 371
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1993 R. Bartl and B. Frisch
About this chapter
Cite this chapter
Bartl, R., Frisch, B. (1993). Osteosclerosis. In: Biopsy of Bone in Internal Medicine: An Atlas and Sourcebook. Current Histopathology, vol 21. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2222-1_11
Download citation
DOI: https://doi.org/10.1007/978-94-011-2222-1_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4985-6
Online ISBN: 978-94-011-2222-1
eBook Packages: Springer Book Archive